ID: ALA4743849

Max Phase: Preclinical

Molecular Formula: C14H11F3N2O2

Molecular Weight: 296.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccc(C(F)(F)F)cc1)Nc1cccc(O)c1

Standard InChI:  InChI=1S/C14H11F3N2O2/c15-14(16,17)9-4-6-10(7-5-9)18-13(21)19-11-2-1-3-12(20)8-11/h1-8,20H,(H2,18,19,21)

Standard InChI Key:  SIQNVINFEPDDQG-UHFFFAOYSA-N

Associated Targets(Human)

Bromodomain adjacent to zinc finger domain protein 1A 48 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 296.25Molecular Weight (Monoisotopic): 296.0773AlogP: 4.06#Rotatable Bonds: 2
Polar Surface Area: 61.36Molecular Species: NEUTRALHBA: 2HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.21CX Basic pKa: CX LogP: 3.69CX LogD: 3.69
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.78Np Likeness Score: -1.26

References

1. Yang Z,Zhou Y,Zhong L.  (2021)  Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation.,  33  [PMID:33333161] [10.1016/j.bmcl.2020.127745]

Source